Know Cancer

or
forgot password

Expression of Oncogenic Human Papillomavirus E6/E7 Protein in Tampon Self-Tests


Phase 0
23 Years
N/A
Not Enrolling
Female
Normal Uterine Cervical Cytology, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Thank you

Trial Information

Expression of Oncogenic Human Papillomavirus E6/E7 Protein in Tampon Self-Tests


Inclusion Criteria:



- Women with cervical dysplasia been referred to conisation.

- Women invited to cervical screening program and with only normal smear and normal
smears in their history.

Exclusion Criteria:

- Women not performing the tampon self-test before conisation.

- Women not performing the tampon self-test at least 3 month after having a normal
PAP-smear taken.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Outcome Measure:

Sensitivity and specificity of the HPV test of the material from the tampon self-test

Outcome Time Frame:

Spring 2008

Safety Issue:

No

Principal Investigator

Hans Svanholm, Head of department

Investigator Role:

Study Director

Investigator Affiliation:

Region Hospital, Department of Pathology

Authority:

Denmark: Danish Dataprotection Agency

Study ID:

TP07-2351

NCT ID:

NCT00526370

Start Date:

August 2007

Completion Date:

July 2008

Related Keywords:

  • Normal Uterine Cervical Cytology
  • Uterine Cervical Dysplasia
  • Uterine Cervical Neoplasms
  • self test
  • PAP smear
  • tampon test
  • E6/E7
  • mRNA
  • HPV
  • Neoplasms
  • Uterine Cervical Neoplasms
  • Uterine Cervical Dysplasia
  • Cervical Intraepithelial Neoplasia

Name

Location